HIGHLIGHTS
- who: Anne T. Nies et al. from the University of Tuebingen, Tuebingen, Germany have published the article: Interaction of Remdesivir with Clinically Relevant Hepatic Drug Uptake Transporters, in the Journal: Pharmaceutics 2021, 369 of 10/03/2021
- what: The authors aimed to analyze whether it is a substrate of the additional important hepatic uptake transporters OATP2B1 and OCT1.
- how: QX was used as internal 4 of 8 Transport data were analyzed with GraphPad Prism 9.0.2 (GraphPad Software Inc [].
SUMMARY
Remdesivir is a small_molecule nucleoside analog inhibitor developed . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.